Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Jay T. Evans

Director, Research Professor

University of Montana

United States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

About

Jay T. Evans serves as the Chief Scientific and Strategy Officer at Inimmune Corporation in the United States. His research focuses on immunology, with recent publications exploring topics such as lipidated TLR agonists, adjuvanted vaccines for Pseudomonas aeruginosa, and strategies for enhancing immune responses against SARS-CoV-2 and fentanyl. He is dedicated to advancing vaccine efficacy and developing innovative approaches to combat infectious diseases.

Articles (8)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2021

Collaborators (3)

David Burkhart

Research Professor

University of Montana Missoula

UNITED STATES

View details

Sharon Reif

Professor

Brandeis University

UNITED STATES

View details

Kendal Ryter

AssociateResearch Faculty

University of Montana

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jay T. Evans

Research Interests

Make your next move.

Explore related searches

About

Articles (8)

Systematic Evaluation of Regiochemistry and Lipidation of Aryl Trehalose Mincle Agonists

Adjuvanted Vaccine Induces Functional Antibodies against Pseudomonas aeruginosa Filamentous Bacteriophages

Co-Delivery of a Novel Lipidated TLR7/8 Agonist and Hemagglutinin-Based Influenza Antigen Using Silica Nanoparticles Promotes Enhanced Immune Responses

Social complexity of a fentanyl vaccine to prevent opioid overdose conference proceedings: Radcliffe institute for advanced study conference proceedings

Co-Delivery of Novel Synthetic TLR4 and TLR7/8 Ligands Adsorbed to Aluminum Salts Promotes Th1-Mediated Immunity against Poorly Immunogenic SARS-CoV-2 RBD

A TLR7/8 agonist increases efficacy of anti-fentanyl vaccines in rodent and porcine models

A lipidated TLR7/8 adjuvant enhances the efficacy of a vaccine against fentanyl in mice

A tractable covalent linker strategy for the production of immunogenic antigen-TLR7/8L bioconjugates

Collaborators (3)

David Burkhart

Sharon Reif

Kendal Ryter

Make your next move.